PT2978840T - Um modelo de barreira hematoencefálica humana derivado de células estaminais - Google Patents

Um modelo de barreira hematoencefálica humana derivado de células estaminais

Info

Publication number
PT2978840T
PT2978840T PT147227383T PT14722738T PT2978840T PT 2978840 T PT2978840 T PT 2978840T PT 147227383 T PT147227383 T PT 147227383T PT 14722738 T PT14722738 T PT 14722738T PT 2978840 T PT2978840 T PT 2978840T
Authority
PT
Portugal
Prior art keywords
stem cells
brain barrier
human blood
model derived
barrier model
Prior art date
Application number
PT147227383T
Other languages
English (en)
Original Assignee
Univ Of Artois
Biocant Park Centro De Inovacao Em Biotecnologia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Of Artois, Biocant Park Centro De Inovacao Em Biotecnologia filed Critical Univ Of Artois
Publication of PT2978840T publication Critical patent/PT2978840T/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/069—Vascular Endothelial cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0697—Artificial constructs associating cells of different lineages, e.g. tissue equivalents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5064—Endothelial cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/165—Vascular endothelial growth factor [VEGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/08—Coculture with; Conditioned medium produced by cells of the nervous system
    • C12N2502/086—Coculture with; Conditioned medium produced by cells of the nervous system glial cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/28—Vascular endothelial cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Vascular Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PT147227383T 2013-03-26 2014-03-26 Um modelo de barreira hematoencefálica humana derivado de células estaminais PT2978840T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PT10685513 2013-03-26

Publications (1)

Publication Number Publication Date
PT2978840T true PT2978840T (pt) 2021-01-06

Family

ID=50685978

Family Applications (1)

Application Number Title Priority Date Filing Date
PT147227383T PT2978840T (pt) 2013-03-26 2014-03-26 Um modelo de barreira hematoencefálica humana derivado de células estaminais

Country Status (6)

Country Link
US (2) US20160040125A1 (pt)
EP (1) EP2978840B1 (pt)
DK (1) DK2978840T3 (pt)
ES (1) ES2841124T3 (pt)
PT (1) PT2978840T (pt)
WO (1) WO2014203087A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11820975B2 (en) * 2014-12-09 2023-11-21 National Research Council Of Canada Human blood brain barrier model
CA3046482A1 (en) * 2016-12-09 2018-06-14 Loma Linda University Health Methods of diagnosing alzheimer's disease and risk of progression to alzheimer's disease
US10457717B2 (en) 2017-02-17 2019-10-29 Denali Therapeutics Inc. Engineered polypeptides
DK3583120T5 (da) 2017-02-17 2024-09-02 Denali Therapeutics Inc Modificerede transferrinreceptorbindende polypeptider
US10143187B2 (en) 2017-02-17 2018-12-04 Denali Therapeutics Inc. Transferrin receptor transgenic models
CN110438063B (zh) * 2018-05-04 2023-04-14 中国人民解放军海军军医大学 人源化类脑器官缺血模型制备及应用
CN108853589A (zh) * 2018-06-11 2018-11-23 上海风劲生物医药科技有限公司 人源化类脑器官在脑损伤运动障碍疾病中的应用
CN116891859B (zh) * 2023-08-10 2024-09-20 云南农业大学 CaRAP2-12基因及在调控辣椒果实中类胡萝卜素合成中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1817410B1 (en) 2004-11-29 2015-01-07 Institut National De La Sante Et De La Recherche Medicale (Inserm) Human blood brain barrier model
JP5113332B2 (ja) * 2005-12-19 2013-01-09 正美 丹羽 血液脳関門インヴィトロ・モデル、病態血液脳関門インヴィトロ・モデル、及びこれを用いた薬物スクリーニング方法、病態血液脳関門機能解析方法、病因解析方法
US20100233132A1 (en) 2006-05-25 2010-09-16 Massachusetts Institute Of Technology Formation of vascular networks using embryonic stem cells
US9902940B2 (en) 2010-06-17 2018-02-27 Wisconsin Alumni Research Foundation Human blood-brain barrier endothelial cells derived from pluripotent stem cells and blood-brain barrier model thereof

Also Published As

Publication number Publication date
US20210380938A1 (en) 2021-12-09
ES2841124T3 (es) 2021-07-07
WO2014203087A1 (en) 2014-12-24
EP2978840A1 (en) 2016-02-03
US20160040125A1 (en) 2016-02-11
DK2978840T3 (da) 2020-11-30
EP2978840B1 (en) 2020-09-30

Similar Documents

Publication Publication Date Title
NO2023032I1 (en) Deucravacitinib or a pharmaceutically acceptable salt thereof
GB2530442B (en) A flowing-water driveable turbine assembly
PT2978840T (pt) Um modelo de barreira hematoencefálica humana derivado de células estaminais
EP3065721C0 (en) FORMULATIONS CONTAINING CYCLOSPORIN A
HK1215459A1 (zh) 個帖子
AU347054S (en) A closure
AU351404S (en) A collimator
GB201303485D0 (en) Skin model
AU343512S (en) Human model
GB2519278B (en) A closure
AU349547S (en) Model
HK1202048A1 (en) A dental capsule
GB201219713D0 (en) A collapsableinfant chair
GB201201920D0 (en) A tie
HK1205230A1 (en) A valve arrangement
GB2532693B (en) A toothbrush
SG2013064209A (en) Creet model
GB201313835D0 (en) A medicament
LU92093B1 (en) Prosthesis head
EP2951667A4 (en) DEFINITION OF A DESIGN PLAN
HK1205585A1 (en) Simulated model comparison
GB2501142B (en) A hairbrush
ZA201307407B (en) A prosthesis
GB201313339D0 (en) A turbine
ZA201309272B (en) A headboard